4.6 Article

Zebrafish Uba1 Degrades IRF3 through K48-Linked Ubiquitination to Inhibit IFN Production

期刊

JOURNAL OF IMMUNOLOGY
卷 207, 期 2, 页码 512-522

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.2100125

关键词

-

资金

  1. National Key Research and Development Program of China [2018YFD0900504]
  2. Youth Innovation Promotion Association [31802338]
  3. National Natural Science Foundation of China [31802338, 32002431]

向作者/读者索取更多资源

Zebrafish Ubal negatively regulates IRF3 by inducing K48-linked ub-proteasomal degradation, affecting the IFN immune balance mechanism.
Fish IFN regulatory factor 3 (IRF3) is a crucial transcription factor in the IFN activation signaling pathway, which leads to IFN production and a positive cycle. Unrestricted IFN expression results in hyperimmune responses and therefore, IFN must be tightly regulated. In the current study, we found that zebrafish Ub-activating enzyme (Ubal) negatively regulated IRF3 via the K-48 ubiquitin proteasome degradation of IRF3. First, ifn expression stimulated by spring viraemia of carp virus infection was blunted by the overexpression of Ubal and enhanced by Ubal knockdown. Afterward, we found that Ubal was localized in the cytoplasm, where it interacted with and degraded IRF3. Functional domains analysis revealed that the C-terminal ubiquitin-fold domain was necessary for IRF3 degradation by Ubal and the N-terminal DNA-binding domain of IRF3 was indispensable for the degradation by Ubal.The degradation of IRF3 was subsequently impaired by treatment with MG132, a ubiquitin proteasome inhibitor. Further mechanism analysis revealed that Ubal induced the K48-linked Ub-proteasomal degradation of IRF3. Finally, the antiviral capacity of IRF3 was significantly attenuated by Ubal. Taken together, our study reveals that zebrafish Ubal interacts with and activates the ubiquitinated degradation of IRF3, providing evidence of the IFN immune balance mechanism in fish.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据